Are you a patient, caregiver, or patient advocate?
Your voice matters.
As part of the ARTEMIS project, we invite you to take a short survey and share your views on digital health, Virtual Twins, and personalised care for people living with liver disease.
It only takes 2 minutes, and your answers will help ensure that future digital health solutions reflect real patient needs and experiences.
Take the survey and help shape the future of liver care.
Let's celebrate Women in Science
We are proud to work alongside inspiring women whose leadership, expertise, and dedication are shaping the future of science and healthcare. On this important day, ELPA is pleased to highlight Irène Vignon-Clementel, Research Director at INRIA and a key contributor to the ARTEMIS project – The Power of Virtual Twins to Fight MASLD. Meet Dr. Cristina Ripoll, a clinician‑scientist leading liver disease research with the ARTEMIS project. By integrating patient voices into her translational work, she’s showing how virtual twin technology can transform the fight against MASLD and bridge the gap between clinical practice and large‑scale European collaborations. Her journey underscores the power of putting patients at the center of innovation.
ARTEMIs Layperson Event Brings Patient Perspectives into the Future of Digital Health
On 27 May 2026, during EASL Congress in Barcelona, the ARTEMIS project held its first layperson event, bringing together ELPA members, national patient representatives, researchers and healthcare professionals to discuss the future of virtual twins in healthcare.
The one-hour session combined presentations led by Prof. Irene Vignon-Clementel (Inria), a pioneer in Digital Human Twins, Dr. Raluca Pais (Pitié-Salpêtrière Hospital, Paris), and Prof. Juan Manuel Pericàs (Vall d’Hebron University Hospital). Moderated by ELPA President Marko Korenjak followed by an interactive Q&A, creating an open dialogue on how patient communities perceive digital twins and the role of trust in adopting innovative technologies in healthcare. Participants learned how the ARTEMIs project aims to accelerate the translation of virtual twins into personalised management for people living with steatotic liver disease (MASLD), while also sharing their expectations, concerns and questions regarding the use of such technologies in clinical practice.
The discussion highlighted the importance of involving people living with liver disease from the earliest stages of research and innovation. Trust, transparency, explainability and patient engagement emerged as key elements for the successful implementation of virtual twin technologies in healthcare.
The event marked an important milestone for ARTEMIs and reinforced ELPA’s commitment to ensuring that the patient voice remains at the centre of research, innovation and future healthcare solutions.
Flyers for patients
Hear from ELPA President, Marko Korenjak
Marko Korenjak
President, European Liver Patients' Association (ELPA)
It is with great pleasure that I extend a warm welcome to you on behalf of the European Liver Patients' Association (ELPA). As the President of ELPA, I am excited to embark on this journey alongside you, as we witness the inception of a groundbreaking project - ARTEMIs. ARTEMIs holds the promise of revolutionizing liver health care, and we eagerly anticipate the results and benefits it will bring to patients. Through this consortium, patients will experience a paradigm shift in their journey towards liver health, with access to innovative solutions and personalized care like never before. At ELPA, we are committed to ensuring that ARTEMIs remains true to its core values of patient- centricity and transparency. We are proud to partner with ARTEMIs, working hand in hand to prioritize the needs and well-being of patients at every stage of the project. As we embark on this journey together, we look forward to witnessing the tangible impact of ARTEMIs on patients' lives. We are insistent on transparency, ensuring that patients have access to clear and accurate information, empowering them to make informed decisions about their health. I extend my gratitude to all the stakeholders involved in making ARTEMIs a reality. Together, we are shaping a future where liver health is prioritized, and patients receive the care and support they deserve. Thank you for your interest in ARTEMIs. Join us as we eagerly await the results and benefits that this innovative project will bring to patients worldwide. We expected to achieve considerable societal impact, by offering clinicians and patients an interactive visualization tool wherein real-world data, as well as risk stratification and early diagnosis predictions are made easy. This is an ambitious project involving 9 countries, 21 partners and a cohort of 7500 patients but ambition is a fundamental ingredient when taking the challenge to improve MASLD patients' hearthcare journy!
Veronika Všetičkova
Head of EU Affairs, European Liver Patients' Association (ELPA)
ARTEMIs represents a pioneering initiative that has the potential to reshape the landscape of liver health care across Europe. At ELPA, we recognize the importance of not only developing innovative solutions but also ensuring their widespread adoption and integration into existing health frameworks. Through our wide-reaching network of partners and stakeholders across Europe, we are committed to facilitating the dissemination of ARTEMIs's findings and recommendations. By engaging with policymakers, healthcare professionals, patient advocacy groups, and other relevant stakeholders, we will work tirelessly to ensure that the benefits of ARTEMIs reach those who need them most - patients. Furthermore, we are dedicated to advocating for the integration of ARTEMIs outcomes into EU health policies and dialogues. By leveraging our position as a trusted voice in the European healthcare arena, we will actively champion the incorporation of evidence-based practices and recommendations from ARTEMIs into policy discussions and decision-making processes. As we move forward, I am confident that our collaborative efforts will pave the way for meaningful change in the field of liver health care. Together with our partners in ARTEMIs and beyond, we will work towards a future where every patient has access to the best possible care and support. Thank you for your interest in ARTEMIs and for joining us on this journey towards a healthier future for all.
